Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Clinical dilemmas in non-alcoholic fatty liver disease / / edited by Roger Williams, Simon D. Taylor-Robinson
| Clinical dilemmas in non-alcoholic fatty liver disease / / edited by Roger Williams, Simon D. Taylor-Robinson |
| Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ : , : Wiley Blackwell, , 2016 |
| Descrizione fisica | 1 online resource (423 p.) |
| Disciplina | 616.3/62 |
| Collana | Clinical Dilemmas (UK) |
| Soggetto topico |
Fatty liver
Liver - Diseases |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-118-92497-5
1-118-92493-2 1-118-92495-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Hype or harm from fatty liver disease? / Stephen H Caldwell and Curt Argo -- Worldwide problem / Geoffrey Farrell and Philip Newsome -- Is insulin resistance the key motive for NAFLD? / Desmond Johnston -- Progression to cirrhosis is more likely in children with NAFLD? / Anil Dhawan -- NAFLD as cause of cryptogenic cirrhosis? / Jay Lefkowitch -- Is NAFLD different in absence of metabolic syndrome? / Yusuf Yilmaz -- Occurrence of noncirrhotic HCC in NAFLD / Stephen Harrison and Dawn Torres -- Fibrosis progression molecular pathways all important? / Anna-Mae Diehl and Dr Wing-Kin Syn -- Can fatty liver of NAFLD be distinguished from that of alcoholic liver disease? / David Kleiner and Elizabeth Brunt -- Are inflammasomes and intestinal microbiota relevant in disease progression to NASH? / M. Bilal Siddiqui, M. Shadab Siddiqui and Arun Sanyal -- Can genetic influence in non-alcoholic fatty liver disease be ignored? / Quentin Anstee -- Is there a mechanistic link between hepatic steatosis and cardiac rather than liver events? / Soo Lim -- Is there a best method for diagnosis of NAFLD? / Vlad Ratziu -- Choice of non-invasive blood tests and FibroScan / Massimo Pinzani and Manolis Tsocatzis -- Are the guidelines AASLD, IASL, EASL and BSG of help? / Jean-Francois Dufour -- How to choose from different imaging modalities and screening techniques / Hero Hussain -- Are the pros outweighed by the cons of obtaining a liver biopsy? / Simon Taylor-Robinson and Jeremy Cobbold -- Screening for NAFLD in high risk population / Nader Lessan -- Balancing calorie restriction, exercise and weight reduction / Nicholas Finer -- Should physicians be prescribing, or patients self-medicating with Orlistat, vitamin E, vitamin D, insulin antagonist, Trental and coffee? / Brent Neuschwander-Tetri and Haripriya Maddur -- Does improvement in hepatic steatosis have a significant favourable effect on the metabolic syndrome, including diabetes? / Jukka Westerbacka -- What are the dangers as well as the true benefits of bariatric surgery? / Andrew Jenkinson -- Liver transplantation : what can it offer? / Roger Williams -- Molecular antagonists, leptin or other hormones in supplementing environmental factors? / Jeremy Tomlinson -- Use of antifibrotic agents in clinical practice / Jonathan Fallowfield -- Better understanding of early development and material influence? / Jude Oben -- Defining the role of metabolic physician / Nicholas Finer. |
| Record Nr. | UNINA-9910136419303321 |
| Chichester, West Sussex ; ; Hoboken, NJ : , : Wiley Blackwell, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in non-alcoholic fatty liver disease / / edited by Roger Williams, Simon D. Taylor-Robinson
| Clinical dilemmas in non-alcoholic fatty liver disease / / edited by Roger Williams, Simon D. Taylor-Robinson |
| Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ : , : Wiley Blackwell, , 2016 |
| Descrizione fisica | 1 online resource (423 p.) |
| Disciplina | 616.3/62 |
| Collana | Clinical Dilemmas (UK) |
| Soggetto topico |
Fatty liver
Liver - Diseases |
| ISBN |
1-118-92497-5
1-118-92493-2 1-118-92495-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Hype or harm from fatty liver disease? / Stephen H Caldwell and Curt Argo -- Worldwide problem / Geoffrey Farrell and Philip Newsome -- Is insulin resistance the key motive for NAFLD? / Desmond Johnston -- Progression to cirrhosis is more likely in children with NAFLD? / Anil Dhawan -- NAFLD as cause of cryptogenic cirrhosis? / Jay Lefkowitch -- Is NAFLD different in absence of metabolic syndrome? / Yusuf Yilmaz -- Occurrence of noncirrhotic HCC in NAFLD / Stephen Harrison and Dawn Torres -- Fibrosis progression molecular pathways all important? / Anna-Mae Diehl and Dr Wing-Kin Syn -- Can fatty liver of NAFLD be distinguished from that of alcoholic liver disease? / David Kleiner and Elizabeth Brunt -- Are inflammasomes and intestinal microbiota relevant in disease progression to NASH? / M. Bilal Siddiqui, M. Shadab Siddiqui and Arun Sanyal -- Can genetic influence in non-alcoholic fatty liver disease be ignored? / Quentin Anstee -- Is there a mechanistic link between hepatic steatosis and cardiac rather than liver events? / Soo Lim -- Is there a best method for diagnosis of NAFLD? / Vlad Ratziu -- Choice of non-invasive blood tests and FibroScan / Massimo Pinzani and Manolis Tsocatzis -- Are the guidelines AASLD, IASL, EASL and BSG of help? / Jean-Francois Dufour -- How to choose from different imaging modalities and screening techniques / Hero Hussain -- Are the pros outweighed by the cons of obtaining a liver biopsy? / Simon Taylor-Robinson and Jeremy Cobbold -- Screening for NAFLD in high risk population / Nader Lessan -- Balancing calorie restriction, exercise and weight reduction / Nicholas Finer -- Should physicians be prescribing, or patients self-medicating with Orlistat, vitamin E, vitamin D, insulin antagonist, Trental and coffee? / Brent Neuschwander-Tetri and Haripriya Maddur -- Does improvement in hepatic steatosis have a significant favourable effect on the metabolic syndrome, including diabetes? / Jukka Westerbacka -- What are the dangers as well as the true benefits of bariatric surgery? / Andrew Jenkinson -- Liver transplantation : what can it offer? / Roger Williams -- Molecular antagonists, leptin or other hormones in supplementing environmental factors? / Jeremy Tomlinson -- Use of antifibrotic agents in clinical practice / Jonathan Fallowfield -- Better understanding of early development and material influence? / Jude Oben -- Defining the role of metabolic physician / Nicholas Finer. |
| Record Nr. | UNINA-9910830823403321 |
| Chichester, West Sussex ; ; Hoboken, NJ : , : Wiley Blackwell, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.]
| Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.] |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Pub., 2005 |
| Descrizione fisica | 1 online resource (342 p.) |
| Disciplina |
616.3
616.362 |
| Altri autori (Persone) | FarrellGeoffrey C |
| Soggetto topico | Fatty liver |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-74334-4
9786610743346 0-470-79721-5 0-470-98743-X 1-4051-4100-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Overview: an introduction to NASH and related fatty liver disorders / Geoffrey C. Farrell ... [et al.] -- Pathology of hepatic steatosis, non-alcoholic steatohepatitis (NASH) and related conditions / Pauline de la M. Hall & Richard Kirsch -- The epidemiology and risk factors of NASH / Arthur J. Mccullough -- Insulin resistance in non-alcoholic fatty liver disease: potential mechanisms and therapies / Varman T. Samuel & Gerald I. Shulman -- NASH as part of the metabolic (insulin resistance) syndrome / Giulio Marchesini & Elisabetta Bugianesi -- NASH is a genetically determined disease / C.P. Day & A.K. Daly -- The pathogenesis of non-alcoholic steatohepatitis: human studies / Arun J. Sanyal -- Animal models of steatohepatitis / Geoffrey C. Farrell -- Fatty acid metabolism and lipotoxicity in the pathogenesis of NASH/NAFLD / Nathan M. Bass & Raphael B. Merriman -- Cytokines and inflammatory recruitment in NASH: experimental and human studies / Z. Li & A.M. Diehl -- Mitochondrial injury and NASH / Bernard Fromenty & Dominique Pessayre -- Cell biology of NASH: fibrosis and cell proliferation / Isabelle A. Leclercq & Yves Horsmans -- Clinical manifestations and diagnosis of NAFLD / Stephen A. Harrison & Brent Neuschwander-Tetri --
The clinical outcome of NAFLD including cryptogenic cirrhosis / Stephen H. Caldwell & Anita Impagliazzo Hylton -- Practical approach to the diagnosis and management of people with fatty liver diseases / Jacob George & Geoffrey C. Farrell -- Management of NASH: current and future perspectives on treatment / Paul Angulo & Keith D. Lindor -- Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation / Anne Burke & Michael R. Lucey -- Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) is not just a 'Western' problem: some perspectives on NASH/NAFLD from the East / Shivakumar Chitturi & Jacob George -- Paediatric NASH / J. Lavine and J.B. Schwimmer -- Steatohepatitis due to intestinal bypass / Christiane Bode & J. Christian Bode -- Specific disorders associated with non-alcoholic fatty liver disease (NAFLD) / Geraldine M. Grant, Vikas Chandhoke & Zobair M. Younossi -- Hepatocellular carcinoma in non-alcoholic fatty liver disease / Vlad Ratziu & Thierry Poynard -- Does NASH or NAFLD contribute to co-morbidity of other liver diseases? / Andrew D. Clouston & Elizabeth E. Powell. |
| Record Nr. | UNINA-9910143304803321 |
| Malden, Mass., : Blackwell Pub., 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.]
| Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.] |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Pub., 2005 |
| Descrizione fisica | 1 online resource (342 p.) |
| Disciplina |
616.3
616.362 |
| Altri autori (Persone) | FarrellGeoffrey C |
| Soggetto topico | Fatty liver |
| ISBN |
1-280-74334-4
9786610743346 0-470-79721-5 0-470-98743-X 1-4051-4100-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Overview: an introduction to NASH and related fatty liver disorders / Geoffrey C. Farrell ... [et al.] -- Pathology of hepatic steatosis, non-alcoholic steatohepatitis (NASH) and related conditions / Pauline de la M. Hall & Richard Kirsch -- The epidemiology and risk factors of NASH / Arthur J. Mccullough -- Insulin resistance in non-alcoholic fatty liver disease: potential mechanisms and therapies / Varman T. Samuel & Gerald I. Shulman -- NASH as part of the metabolic (insulin resistance) syndrome / Giulio Marchesini & Elisabetta Bugianesi -- NASH is a genetically determined disease / C.P. Day & A.K. Daly -- The pathogenesis of non-alcoholic steatohepatitis: human studies / Arun J. Sanyal -- Animal models of steatohepatitis / Geoffrey C. Farrell -- Fatty acid metabolism and lipotoxicity in the pathogenesis of NASH/NAFLD / Nathan M. Bass & Raphael B. Merriman -- Cytokines and inflammatory recruitment in NASH: experimental and human studies / Z. Li & A.M. Diehl -- Mitochondrial injury and NASH / Bernard Fromenty & Dominique Pessayre -- Cell biology of NASH: fibrosis and cell proliferation / Isabelle A. Leclercq & Yves Horsmans -- Clinical manifestations and diagnosis of NAFLD / Stephen A. Harrison & Brent Neuschwander-Tetri --
The clinical outcome of NAFLD including cryptogenic cirrhosis / Stephen H. Caldwell & Anita Impagliazzo Hylton -- Practical approach to the diagnosis and management of people with fatty liver diseases / Jacob George & Geoffrey C. Farrell -- Management of NASH: current and future perspectives on treatment / Paul Angulo & Keith D. Lindor -- Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation / Anne Burke & Michael R. Lucey -- Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) is not just a 'Western' problem: some perspectives on NASH/NAFLD from the East / Shivakumar Chitturi & Jacob George -- Paediatric NASH / J. Lavine and J.B. Schwimmer -- Steatohepatitis due to intestinal bypass / Christiane Bode & J. Christian Bode -- Specific disorders associated with non-alcoholic fatty liver disease (NAFLD) / Geraldine M. Grant, Vikas Chandhoke & Zobair M. Younossi -- Hepatocellular carcinoma in non-alcoholic fatty liver disease / Vlad Ratziu & Thierry Poynard -- Does NASH or NAFLD contribute to co-morbidity of other liver diseases? / Andrew D. Clouston & Elizabeth E. Powell. |
| Record Nr. | UNISA-996214588203316 |
| Malden, Mass., : Blackwell Pub., 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.]
| Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.] |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Pub., 2005 |
| Descrizione fisica | 1 online resource (342 p.) |
| Disciplina |
616.3
616.362 |
| Altri autori (Persone) | FarrellGeoffrey C |
| Soggetto topico | Fatty liver |
| ISBN |
1-280-74334-4
9786610743346 0-470-79721-5 0-470-98743-X 1-4051-4100-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Overview: an introduction to NASH and related fatty liver disorders / Geoffrey C. Farrell ... [et al.] -- Pathology of hepatic steatosis, non-alcoholic steatohepatitis (NASH) and related conditions / Pauline de la M. Hall & Richard Kirsch -- The epidemiology and risk factors of NASH / Arthur J. Mccullough -- Insulin resistance in non-alcoholic fatty liver disease: potential mechanisms and therapies / Varman T. Samuel & Gerald I. Shulman -- NASH as part of the metabolic (insulin resistance) syndrome / Giulio Marchesini & Elisabetta Bugianesi -- NASH is a genetically determined disease / C.P. Day & A.K. Daly -- The pathogenesis of non-alcoholic steatohepatitis: human studies / Arun J. Sanyal -- Animal models of steatohepatitis / Geoffrey C. Farrell -- Fatty acid metabolism and lipotoxicity in the pathogenesis of NASH/NAFLD / Nathan M. Bass & Raphael B. Merriman -- Cytokines and inflammatory recruitment in NASH: experimental and human studies / Z. Li & A.M. Diehl -- Mitochondrial injury and NASH / Bernard Fromenty & Dominique Pessayre -- Cell biology of NASH: fibrosis and cell proliferation / Isabelle A. Leclercq & Yves Horsmans -- Clinical manifestations and diagnosis of NAFLD / Stephen A. Harrison & Brent Neuschwander-Tetri --
The clinical outcome of NAFLD including cryptogenic cirrhosis / Stephen H. Caldwell & Anita Impagliazzo Hylton -- Practical approach to the diagnosis and management of people with fatty liver diseases / Jacob George & Geoffrey C. Farrell -- Management of NASH: current and future perspectives on treatment / Paul Angulo & Keith D. Lindor -- Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation / Anne Burke & Michael R. Lucey -- Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) is not just a 'Western' problem: some perspectives on NASH/NAFLD from the East / Shivakumar Chitturi & Jacob George -- Paediatric NASH / J. Lavine and J.B. Schwimmer -- Steatohepatitis due to intestinal bypass / Christiane Bode & J. Christian Bode -- Specific disorders associated with non-alcoholic fatty liver disease (NAFLD) / Geraldine M. Grant, Vikas Chandhoke & Zobair M. Younossi -- Hepatocellular carcinoma in non-alcoholic fatty liver disease / Vlad Ratziu & Thierry Poynard -- Does NASH or NAFLD contribute to co-morbidity of other liver diseases? / Andrew D. Clouston & Elizabeth E. Powell. |
| Record Nr. | UNINA-9910830283403321 |
| Malden, Mass., : Blackwell Pub., 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.]
| Fatty liver disease [[electronic resource] ] : NASH and related disorders / / edited by Geoffrey C. Farrell ... [et al.] |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Pub., 2005 |
| Descrizione fisica | 1 online resource (342 p.) |
| Disciplina |
616.3
616.362 |
| Altri autori (Persone) | FarrellGeoffrey C |
| Soggetto topico | Fatty liver |
| ISBN |
1-280-74334-4
9786610743346 0-470-79721-5 0-470-98743-X 1-4051-4100-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Overview: an introduction to NASH and related fatty liver disorders / Geoffrey C. Farrell ... [et al.] -- Pathology of hepatic steatosis, non-alcoholic steatohepatitis (NASH) and related conditions / Pauline de la M. Hall & Richard Kirsch -- The epidemiology and risk factors of NASH / Arthur J. Mccullough -- Insulin resistance in non-alcoholic fatty liver disease: potential mechanisms and therapies / Varman T. Samuel & Gerald I. Shulman -- NASH as part of the metabolic (insulin resistance) syndrome / Giulio Marchesini & Elisabetta Bugianesi -- NASH is a genetically determined disease / C.P. Day & A.K. Daly -- The pathogenesis of non-alcoholic steatohepatitis: human studies / Arun J. Sanyal -- Animal models of steatohepatitis / Geoffrey C. Farrell -- Fatty acid metabolism and lipotoxicity in the pathogenesis of NASH/NAFLD / Nathan M. Bass & Raphael B. Merriman -- Cytokines and inflammatory recruitment in NASH: experimental and human studies / Z. Li & A.M. Diehl -- Mitochondrial injury and NASH / Bernard Fromenty & Dominique Pessayre -- Cell biology of NASH: fibrosis and cell proliferation / Isabelle A. Leclercq & Yves Horsmans -- Clinical manifestations and diagnosis of NAFLD / Stephen A. Harrison & Brent Neuschwander-Tetri --
The clinical outcome of NAFLD including cryptogenic cirrhosis / Stephen H. Caldwell & Anita Impagliazzo Hylton -- Practical approach to the diagnosis and management of people with fatty liver diseases / Jacob George & Geoffrey C. Farrell -- Management of NASH: current and future perspectives on treatment / Paul Angulo & Keith D. Lindor -- Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation / Anne Burke & Michael R. Lucey -- Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) is not just a 'Western' problem: some perspectives on NASH/NAFLD from the East / Shivakumar Chitturi & Jacob George -- Paediatric NASH / J. Lavine and J.B. Schwimmer -- Steatohepatitis due to intestinal bypass / Christiane Bode & J. Christian Bode -- Specific disorders associated with non-alcoholic fatty liver disease (NAFLD) / Geraldine M. Grant, Vikas Chandhoke & Zobair M. Younossi -- Hepatocellular carcinoma in non-alcoholic fatty liver disease / Vlad Ratziu & Thierry Poynard -- Does NASH or NAFLD contribute to co-morbidity of other liver diseases? / Andrew D. Clouston & Elizabeth E. Powell. |
| Record Nr. | UNINA-9910841607803321 |
| Malden, Mass., : Blackwell Pub., 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [[electronic resource] /] / Masato Yoneda ... [et al.]
| Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [[electronic resource] /] / Masato Yoneda ... [et al.] |
| Autore | Yoneda Masato |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2010 |
| Descrizione fisica | 1 online resource (64 p.) |
| Disciplina | 616.3/62 |
| Collana |
Metabolic diseases--laboratory and clinical research
Novinka |
| Soggetto topico |
Fatty liver
Insulin resistance |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61728-480-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions. |
| Record Nr. | UNINA-9910461090903321 |
Yoneda Masato
|
||
| New York, : Nova Biomedical Books, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [[electronic resource] /] / Masato Yoneda ... [et al.]
| Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [[electronic resource] /] / Masato Yoneda ... [et al.] |
| Autore | Yoneda Masato |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2010 |
| Descrizione fisica | 1 online resource (64 p.) |
| Disciplina | 616.3/62 |
| Altri autori (Persone) | YonedaMasato |
| Collana |
Metabolic diseases--laboratory and clinical research
Novinka |
| Soggetto topico |
Fatty liver
Insulin resistance |
| ISBN | 1-61728-480-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions. |
| Record Nr. | UNINA-9910790067903321 |
|
Yoneda Masato
|
||
| New York, : Nova Biomedical Books, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [[electronic resource] /] / Masato Yoneda ... [et al.]
| Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) [[electronic resource] /] / Masato Yoneda ... [et al.] |
| Autore | Yoneda Masato |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2010 |
| Descrizione fisica | 1 online resource (64 p.) |
| Disciplina | 616.3/62 |
| Altri autori (Persone) | YonedaMasato |
| Collana |
Metabolic diseases--laboratory and clinical research
Novinka |
| Soggetto topico |
Fatty liver
Insulin resistance |
| ISBN | 1-61728-480-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions. |
| Record Nr. | UNINA-9910823704103321 |
|
Yoneda Masato
|
||
| New York, : Nova Biomedical Books, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / / edited by Ju-Seop Kang
| Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / / edited by Ju-Seop Kang |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2023 |
| Descrizione fisica | 1 online resource (ix, 156 pages) : illustrations |
| Disciplina | 616.362 |
| Soggetto topico | Fatty liver |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis. |
| Altri titoli varianti | Non-alcoholic Fatty Liver Disease |
| Record Nr. | UNINA-9910647203903321 |
| London : , : IntechOpen, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Fatty liver
(21)
- Liver - Diseases (7)
- Insulin resistance (5)
- Diseases (1)